BioCorRx Inc.
BICX
$0.3859
$0.059918.37%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -22.19% | 1.58% | -27.70% | -11.80% | 6.08% |
| Total Depreciation and Amortization | -30.90% | -30.03% | -61.68% | 126.30% | 1.86% |
| Total Amortization of Deferred Charges | -39.77% | 23.85% | 29.75% | 51.67% | 16.51% |
| Total Other Non-Cash Items | 615.49% | -51.27% | 422.22% | -52.93% | -27.98% |
| Change in Net Operating Assets | -64.60% | 56.31% | 347.53% | -66.42% | 237.19% |
| Cash from Operations | -135.35% | 55.28% | 36.36% | -52.30% | 38.67% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 502.69% | -84.17% | -12.17% | 38.06% | 61,900.00% |
| Total Debt Repaid | -2,250.00% | 0.00% | 0.00% | -33.33% | 99.15% |
| Issuance of Common Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 490.03% | -84.23% | -15.16% | 42.91% | -45.21% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 91.05% | -358.22% | 139.36% | -122.98% | -539.06% |
